For hypertensive patients, there are three major cognitive blind spots in daily management: nearly 68% of patients believe that "asymptomatic withdrawal can be stopped", 42% of the population fall into the misunderstanding of "only testing but not intervention", and as many as 75% of drug users have never verified whether the blood pressure is up to standard. Behind these data, the industry pain points of traditional sphygmomanometer with single function, isolated data, and lack of professional guidance are reflected. The Aole R & D team spent three years working on the problem, deeply integrating the two-way oscilloscope method with the fourth-generation intelligent algorithm, so that the measurement accuracy can reach the 3mmHg medical device standard. At the same time, relying on the natural language processing ability of the iFLYTEK Mars model, it has created the first intelligent end point with healthy dialogue function.

At seven o'clock in the morning, Auntie Wang, who lives in Hangzhou, wore her arm strap as usual, the AI sphygmomanometer, and a soft voice prompt sounded: "Diastolic blood pressure 92mmHg, systolic blood pressure 148mmHg, Auntie Wang said," In the past, I always thought that taking medicine on time was enough, but now I know that blood pressure fluctuations need to be adjusted dynamically. "The sphygmomanometer used the health report generated by the Xunfei Xiaoyi APP, and she found the hidden pattern of blood pressure rising at night. After adjusting the medication plan in time, the symptoms of dizziness in the morning were significantly relieved. When blood pressure is at high risk, the AI assistant will provide emergency guidance measures as soon as possible to avoid missing the golden treatment time and reduce the risk of sudden This app not only allows children to remotely view their parents' blood pressure trends, but also converts continuous monitoring data into visual charts, providing doctors with a key basis for evaluating the effectiveness of medication.